These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 27639441)

  • 1. Human teratogens and genetic phenocopies. Understanding pathogenesis through human genes mutation.
    Cassina M; Cagnoli GA; Zuccarello D; Di Gianantonio E; Clementi M
    Eur J Med Genet; 2017 Jan; 60(1):22-31. PubMed ID: 27639441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil embryopathy: A newly recognized teratogenic syndrome.
    Perez-Aytes A; Marin-Reina P; Boso V; Ledo A; Carey JC; Vento M
    Eur J Med Genet; 2017 Jan; 60(1):16-21. PubMed ID: 27639443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors.
    Brent RL
    Pediatrics; 2004 Apr; 113(4 Suppl):957-68. PubMed ID: 15060188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of thalidomide use in birth defects in Brazil.
    Sales Luiz Vianna F; Kowalski TW; Fraga LR; Sanseverino MT; Schuler-Faccini L
    Eur J Med Genet; 2017 Jan; 60(1):12-15. PubMed ID: 27638330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe facial clefts in acrofacial dysostosis: a consequence of prenatal exposure to mycophenolate mofetil?
    Schoner K; Steinhard J; Figiel J; Rehder H
    Obstet Gynecol; 2008 Feb; 111(2 Pt 2):483-6. PubMed ID: 18238994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance of CD-1 and ogg1 DNA repair-deficient mice to thalidomide and hydrolysis product embryopathies in embryo culture.
    Lee CJ; Gonçalves LL; Wells PG
    Toxicol Sci; 2011 Jul; 122(1):146-56. PubMed ID: 21505090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil in pregnancy after renal transplantation: a case of major fetal malformations.
    Le Ray C; Coulomb A; Elefant E; Frydman R; Audibert F
    Obstet Gynecol; 2004 May; 103(5 Pt 2):1091-4. PubMed ID: 15121619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal exposure to teratogenic medications in the era of Risk Evaluation and Mitigation Strategies.
    Sarayani A; Albogami Y; Thai TN; Smolinski NE; Patel P; Wang Y; Nduaguba S; Rasmussen SA; Winterstein AG
    Am J Obstet Gynecol; 2022 Aug; 227(2):263.e1-263.e38. PubMed ID: 35032444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide-induced teratogenesis: history and mechanisms.
    Vargesson N
    Birth Defects Res C Embryo Today; 2015 Jun; 105(2):140-56. PubMed ID: 26043938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature.
    Anderka MT; Lin AE; Abuelo DN; Mitchell AA; Rasmussen SA
    Am J Med Genet A; 2009 Jun; 149A(6):1241-8. PubMed ID: 19441125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and molecular teratology of fetal hydantoin syndrome.
    Buehler BA; Rao V; Finnell RH
    Neurol Clin; 1994 Nov; 12(4):741-8. PubMed ID: 7845340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathy.
    Ornoy A
    Reprod Toxicol; 2007 Jul; 24(1):31-41. PubMed ID: 17548185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Teratology and epidemiology in the study of environmental teratogens].
    Cayré R; Sánchez-Gómez C; Moreno-Rodríguez RA; de la Cruz MV
    Bol Med Hosp Infant Mex; 1992 Jul; 49(7):397-403. PubMed ID: 1418645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new mammalian model system for thalidomide teratogenesis: Monodelphis domestica.
    Sorensen D; Sackett A; Urban DJ; Maier J; Vargesson N; Sears KE
    Reprod Toxicol; 2017 Jun; 70():126-132. PubMed ID: 28130151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On certain embryopathies induced by teratogenic agents (author's transl].
    Majewski F
    Monatsschr Kinderheilkd (1902); 1977 Jun; 125(6):609-20. PubMed ID: 329123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic toxicities of human teratogens.
    Bishop JB; Witt KL; Sloane RA
    Mutat Res; 1997 Dec; 396(1-2):9-43. PubMed ID: 9434858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teratogens and teratogenesis: general principles of clinical teratology.
    Frias JL; Thomas IT
    Ann Clin Lab Sci; 1988; 18(2):174-9. PubMed ID: 3289471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorothalidomide: a characterization of maternal and developmental toxicity in rabbits and mice.
    Lee CJ; Shibata N; Wiley MJ; Wells PG
    Toxicol Sci; 2011 Jul; 122(1):157-69. PubMed ID: 21505091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced teratogenesis.
    FRASER FC
    Can Med Assoc J; 1962 Sep; 87(13):683-4. PubMed ID: 13894748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal exposure to environmental factors and congenital limb defects.
    Alexander PG; Clark KL; Tuan RS
    Birth Defects Res C Embryo Today; 2016 Sep; 108(3):243-273. PubMed ID: 27768243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.